Impact of intestinal dysbiosis-related drugs on the efficacy of immune checkpoint inhibitors in clinical practice
2020; Springer Science+Business Media; Volume: 22; Issue: 10 Linguagem: Inglês
10.1007/s12094-020-02315-9
ISSN1699-3055
AutoresElisabeth Pérez-Ruíz, Jerónimo Jiménez-Castro, Miguel‐Ángel Berciano‐Guerrero, Javier Valdivia, S. Estalella-Mendoza, Fátima Toscano, María Rodríguez de la Borbolla Artacho, Margarita Garrido-Siles, María José Martínez Bautista, Rosa Villatoro Roldán, Francisco Rivas‐Ruiz, Esteban Nogales‐Fernández, Cristina Morales, Begoña Pérez-Valderrama, Luis de la Cruz‐Merino, Ángel Inoriza Rueda,
Tópico(s)Immune Cell Function and Interaction
Referência(s)